Nolla Health receives approval for automated prescription system

Regulators in Utah have given healthcare startup Nolla Health permission to run a trial program where artificial intelligence software evaluates patients and writes initial prescriptions without direct physician oversight. According to reporting by Bloomberg and announcements from the company, this marks a significant shift from previous medical software that only handled automated refills or assisted human doctors. The initial launch focuses exclusively on acne treatment through an application called Nolla Derm.

If successful, fully automated prescribing could dramatically reduce wait times and lower the cost of managing routine medical issues. Company representative Luis Wenus noted on social media that everyday skin conditions consume valuable appointment slots, leaving fewer resources for complex cases like skin cancer. Allowing software to independently direct the entire patient experience, from diagnosis to prescription and follow up care, could make basic medical support accessible to populations that currently lack access to specialists.

Significant questions remain regarding patient safety, legal liability, and regulatory acceptance outside of Utah. It is still unclear how the software will handle misdiagnoses or adverse reactions to medications when no human clinician reviews the original decision. Additionally, while acne care carries relatively low risks, moving this autonomous model into broader fields such as women's health may face severe resistance from medical boards and insurers who demand human accountability before paying for automated treatments.